Neurofibromatosis type-1-associated diffuse lung disease in children

Area of Science:

• Pediatric Pulmonology
• Medical Genetics
• Radiology

Background:

• Diffuse lung disease in neurofibromatosis type-1 (NF-1) is primarily documented in adults.
• The exact mechanisms linking NF-1 to lung pathology remain unclear.
• Distinctive CT findings (blebs, bullae, cysts) and histopathology suggest NF-1 as a cause, separate from smoking-related emphysema.

Purpose of the Study:

• To investigate the prevalence of diffuse lung disease in pediatric patients with NF-1.
• To evaluate the characteristic computed tomography (CT) findings associated with this condition in children.

Main Methods:

• Retrospective review of spinal CT scans (2004-2018) in pediatric NF-1 patients (group 1).
• Comparison with a control group of pediatric patients with severe scoliosis but without NF-1 (group 2).
• Analysis focused on differentiating NF-1-related lung disease from scoliosis-induced changes.

Main Results:

• Diffuse lung disease was identified in 19.4% (6/31) of pediatric NF-1 patients.
• No cases of diffuse lung disease were found in the control group (0/31).
• The observed difference between groups was statistically significant (P=.01), with all affected patients showing subpleural blebs, bullae, or cysts.

Conclusions:

• The findings support diffuse lung disease as a direct manifestation of neurofibromatosis type-1.
• Early onset of this lung condition is possible in pediatric NF-1 patients.
• CT imaging can reveal characteristic signs of NF-1-associated lung disease in children.